戻る
Cynata Therapeutics Ltd (CYYNF)価格
CYYNF 株価推移チャート
CYYNF 収入
Cynata Therapeutics Ltd
$0.15
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.15
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.15
始値
$0.15
当日レンジ
$0.11 - $0.15
52週レンジ
$0.08 - $0.15
取引高
220
平均取引高
32
1株当たり利益(TTM)
-0.03
配当利回り
--
時価総額
$35.6M
CYYNFとは何ですか？
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. The firm is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells (iPSCs) to manufacture cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale. Its product candidates include CYP-001, CYP-004 and CYP-006TK. CYP-001 is under Phase II clinical trials with a focus on treatment for steroid-resistant acute graft versus host disease (GvHD) and a Phase 1/II trial in patients undergoing kidney transplantation. CYP-006TK is a Cymerus iPSC-derived MSC topical wound dressing product candidate. This product is used in the Company’s Phase I clinical trial in diabetic foot ulcers (DFU). CYP-004, is an iPSC-derived MSC product for intra-articular injection (injection into a joint), is ongoing with a Phase III trial in patients with osteoarthritis of the knee.